What is the NOAEL for Sulisobenzone?
Sulisobenzone has 49 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP_ICE_endocrine.
Also known as: 2-Hydroxy-4-methoxy-5-sulfobenzophenone, Benzenesulfonic acid, 5-benzoyl-4-hydroxy-2-methoxy-, Benzophenone 4, 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid, BRN 2889165 (+3 more)
CAS 4065-45-6
Sulisobenzone (CAS 4065-45-6) is a chemical substance. Key regulatory status: REACH registered, 9 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS, ECHA REACH.
View cosmetic safety profile for Sulisobenzone (Benzophenone-4) →
Sulisobenzone is classified GHS Danger (H315, H317, H318, H319, H335) in the chemicals database but is allowed in EU cosmetics.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| IFRA Transparency | IFRA | IFRA |
| Canada; consumer_product; Substances in Products - Canada (4/2014) | Government of Canada | CPCat |
| children; Europe; Personal care - body hygiene - body wash | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care - hair styling and care - shampoo | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| children; Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| pharmaceutical | US International Trade Commission | CPCat |
| Canada; pharmaceutical | DrugBank | DrugBank |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 59 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | dermal | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1239 | mg/kg/day | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1239 | mg/kg/day | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1250 | mg/kg/day | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1.05 | uL/min/10^6 cells | Clint | - | Human | NTP_ICE_adme_parameters |
| =10 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| =61.7 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 1W6L629B4K | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 1W6L629B4K | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 1W6L629B4K | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 1W6L629B4K | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0.00942 | fraction | Fu | - | Human | NTP_ICE_adme_parameters |
| =3530 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
| =59 | - | NOAEL | - | - | SCCS_vision_codex |
| =59 | - | NOAEL | - | - | SCCS_vision_codex |
| =59 | - | NOAEL | - | - | SCCS_vision_codex |
| =59 | - | NOAEL | - | - | SCCS_vision_codex |
| =620 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =620 | - | NOAEL | - | - | SCCS_vision_codex |
| =620 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =620 | - | NOAEL | - | - | SCCS_vision_codex |
| =620 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =620 | - | NOAEL | - | - | SCCS_vision_codex |
| =620 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =620 | - | NOAEL | - | - | SCCS_vision_codex |
| =1239 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1239 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =1239 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1239 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =1239 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1239 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =1239 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1239 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =1250 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1250 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1250 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| =1250 | mg/kg/day | NOAEL | - | rat | SCCS_vision_codex |
| 620 | mg/kg bw/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 620 | mg/kg bw/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1239 | mg/kg bw/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1239 | mg/kg bw/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
Showing 49 of 49 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Sulisobenzone | 223-772-2 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1660/23 | 27 March 2024 | safe with restrictions | up to 5% | Potential endocrine disrupting properties; assessed safe considering all aggregated dermal exposures |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Sulisobenzone has 49 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP_ICE_endocrine.
Sulisobenzone appears on 8 regulatory/inventory lists including inert_ingredient; non_food_use; Pesticides, IFRA Transparency, Canada; consumer_product; Substances in Products - Canada (4/2014), and 5 more. Source: EPA CPDat.
Yes, Sulisobenzone is also indexed as a cosmetic ingredient under the name Sulisobenzone (Benzophenone-4). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Sulisobenzone is classified GHS Danger (H315, H317, H318, H319, H335) in the chemicals database but is allowed in EU cosmetics.
Sulisobenzone also appears in cosmetics, pharmaceutical databases.